~~<i id='A2D4D3D71A'><strike id='A2D4D3D71A'><tt id='A2D4D3D71A'><pre id='A2D4D3D71A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

hotspot

author：knowledge 2025-10-01 15:28:27 - browse：4951

Sanofi will license a new CRISPR enzyme from the startup Scribe Therapeutics in a bid to be the first to develop a safer, simpler, and more scalable cure for sickle cell disease.

The French drugmaker will pay Scribe $40 million upfront and promise another $1.2 billion in potential milestones to license a DNA-cutting enzyme called CasX for use in a potential single-infusion treatment for the serious blood disorder — what’s known as in vivo therapy.CasX was discovered in CRISPR pioneer Jennifer Doudna’s lab, which subsequently spun out Scribe.

Scribe was planning to announce the news Tuesday, but it was published early Monday by GEN.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Wildfire smoke exposes gaps in outdoor worker protections
Next article： How the messy conversation about Dolly changed bioethics

focus

hotspot

focus

knowledge

hotspot

knowledge

1:29Rep.RubenGallego,D-Ariz.,holdsatownhallinBuckeye,Ariz.,Aug.6,ashecampaignsfortheU.S.Senate.ABCNe

WSS

Grad students accuse University of California of wage theft

House panel takes first step toward fixing drug shortages

'A game

Biden will tout long

Mississippi candidates for statewide offices square off in party primaries

Trump Jan. 6 attorney John Lauro is ex

focus

hotspot

focus

Medical leaders decry Supreme Court decision on affirmative action

House panel takes first step toward fixing drug shortages

Novavax promises a turnaround & Lilly roils the obesity market

Chamber of Commerce, DOJ clash in court over drug prices

Medical records are filled with copy

The UK government moves asylum

The high cost of giving birth even with insurance

Akili changes sales model for its ADHD video game treatment

Medicare details structure of new drug price negotiation program

People with substance use disorder deserve online privacy

hotspot

In medicine, common shorthands can shortchange care

Grad students accuse University of California of wage theft

Thousands of Marines and sailors deploy to Middle East to deter Iran from seizing ships

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

Teen said 'homophobic slurs' before O'Shae Sibley killing: Criminal complaint

DeSantis and Newsom agree to Sean Hannity debate, then disagree on the rules

focus

knowledge

hotspot

knowledge